Onyvax Limited Identifies a Biomarker Profile That Could be Predictive of Response to Cancer Vaccines
11/11/2008 4:34:43 PM
More...
|
Onyvax Limited European Phase IIB Clinical Trial Completes Enrolment
3/17/2008 11:59:28 AM
More...
|
Onyvax Limited Funding Shot for Cell-Based Vaccines
1/14/2008 10:41:45 AM
More...
|
Onyvax Limited Release: Phase IIb Clinical Trial Of Onyvax-P In Early Stage Prostate Cancer Initiated In United States
9/28/2007 11:29:37 AM
More...
|
Onyvax Limited Raises £8 Million To Advance Development Of Prostate Cancer Vaccine
5/8/2006 4:55:58 PM
More...
|
Eden Biodesign And Onyvax Limited Announce Biomanufacturing Contract
4/6/2006 1:54:53 PM
More...
|
Onyvax Limited Release: University of Michigan Researchers Zero-In On CD55
3/27/2006 2:18:12 PM
More...
|
Onyvax Limited Release: Onyvax-105 Cancer Vaccine Shows Encouraging Clinical Results In Osteosarcoma Patients After Intensive Chemotherapy
10/19/2005 5:13:13 PM
More...
|
Asterand, Inc. Announces New Cell Lines To Advance Prostate Cancer Research
10/19/2005 5:10:01 PM
More...
|
Onyvax Limited Publishes Results Of Phase II Prostate Cancer Vaccine Showing Significant Steps Towards Delaying Disease Progression
10/19/2005 5:09:13 PM
More...
|